Connect with us

COVID19

COVID-19 Pandemic ‘Out of Control’, Says UN Chief

The UN chief told journalists yesterday that “the grimmest of milestones” is upon us.

Published

on

NEW YORK (United States): The U.N. Secretary-General warned Wednesday the coronavirus pandemic is “out of control,” and he called for global solidarity in making a future vaccine affordable and available to all.

“The virus is the No. 1 global security threat in our world today,” Antonio Guterres told reporters.

Guterres spoke ahead of Tuesday’s start of the U.N. General Assembly annual debate, which typically draws more than a hundred presidents, prime ministers and other senior officials to New York each year. But due to the pandemic, leaders will send pre-recorded video messages, and side meetings will be held virtually.


Recognizing that many pin their hopes on a vaccine, he said, “let’s be clear: there is no panacea in a pandemic”.

“A vaccine alone cannot solve this crisis, certainly not in the near term”, stressed the world’s top diplomat. “We need to massively expand new and existing tools that can respond to new cases and provide vital treatment to suppress transmission and save lives, especially over the next 12 months”.

He emphasized that because the virus “respects no borders”, a vaccine must be seen as “a global public good”, affordable and available to all, but it requires “a quantum leap in funding”.


Moreover, people must be willing to be vaccinated, but a proliferation of misinformation on vaccines is fueling vaccine-hesitancy, and igniting wild conspiracy theories, noted the UN chief.

He spoke of “alarming reports” that large populations in various countries are reluctant, or outright refusing, to take a new coronavirus vaccine.

“In the face of this lethal disease, we must do our utmost to halt deadly misinformation”, affirmed the Secretary-General.

I’m very worried. The pandemic has shown us the enormous fragility of the world. Not only in relation to COVID-19 but also in relation to climate change, to the lawlessness in cyberspace, the risks of nuclear proliferation, to the impacts of inequality in the cohesion of societies.

A microscopic virus has put us on our knees. This should lead to a lot of humility in world leaders, and to unity and solidarity in the fight against COVID-19. But we know that there has been no unity. Each country has adopted its own strategy, and we see the results: the virus has progressed everywhere. 


In developing countries, people are suffering so much from this lack of solidarity. This is negative for everybody because if we are not able to properly address COVID-19 in these countries, the virus goes back and forth and we will all pay a heavy price, even in the richest countries in the world,” he added.

There have been nearly 30 million confirmed cases worldwide of COVID-19, the disease caused by the coronavirus, and more than 936,000 deaths, according to Johns Hopkins University, which tracks global data on the virus.

Continue Reading
Comments

COVID19

COVID-19: Clinical Trial Of Ayurvedic Remedy Shows Encouraging Results

Over 85% of patients on the natural protocol tested negative for coronavirus on day 5.

Published

on

MUMBAI (Maharashtra): A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines. The interim report on a combination treatment of an Ayurvedic remedy called ‘Immunofree’ by Corival Life Sciences, and Nutraceutical called ‘Reginmune’ by Biogetica have shown exceptional results as against the present government SOP of conventional medicines for coronavirus treatment.

When compared with conventional treatments for COVID-19, Ayurvedic treatment has shown quicker improvement too. 86.66 per cent of patients undergoing a natural treatment tested negative by the fifth day vs 60 per cent patients on conventional treatment.

On the 10th day, all patients tested negative for the virus after Ayurvedic treatment.

Furthermore, numerous tests such as C reactive protein, Procalcitonin, D Dimer and RT-PCR for novel coronavirus are also showing 20 to 60 per cent better improvement for the natural treatment, when compared to conventional treatment.


Numerous subjective endpoints such as body pain and fatigue are also leaning towards natural treatment. Both Clinician’s Global Assessment of Symptoms and Subject’s Global Assessment of Symptoms clearly showed improvements on both arms showing more significant data in the test group.

The three hospitals where Ayurvedic clinical trials are taking place in India are Government Medical Hospital, Srikakulam Andhra Pradesh; Parul Sevashram Hospital, Vadodara, Gujarat, and Lokmanya Hospital Pune, Maharashtra.

The conventional treatment in use depends on the severity of the patient and includes HCQ, Azithromycin, Favipiravir and Cetirizine. This trial also has broader inclusion criteria than others conducted on natural medicine as it includes patients up to 70 years old, with low oxygen saturation and co-morbidities.


It is significant to note that none of the patients on the natural treatment progressed past moderate, needed ventilators or had any adverse events. These precedent-setting results have led to accelerated enrolment into this trial and statistically significant results should be ready by month-end.

Continue Reading

COVID19

COVID-19: IIT Kharagpur Develops Telemedicine Tech For Corona Homecare

The system is accessible by any standard internet browser and also from a mobile device.

Published

on

KHARAGPUR (West Bengal): Amid the world, and India, struggling with the mayhem caused by COVID-19 pandemic. researchers at IIT Kharagpur’s Department of Computer Science & Engineering have developed a telemedicine system, iMediX.

The system integrates homecare with healthcare services from the hospital. Considering the emergent needs due to the pandemic, the system facilitates critical health care support to the patients at their doorsteps through remote consultation by a physician.

The system is accessible by any standard internet browser and also from a mobile device.

In this system, a patient signs up to get an account by providing his/her Email ID or Mobile number. Then the patient can make a request for consultation by choosing a Department of the hospital, entering the chief complaints and uploading necessary scanned medical records. The hospital administration processes the request and assigns a doctor. The doctor after logging in sets an appointment date and time for the patient and the system communicates the information to the patient by Email and SMS. On the day of the visit, the doctor consults the patient using video conferencing and advises the patient by writing a prescription, which is sent by Email to the patient. The patient can also download the prescription from his or her account.


Prof. Jayanta Mukhopadhyay, the lead researcher in this field remarked, “As the number of cases of home isolation and home quarantine is increasing, the system will cater to the needs of the present situation. It would be useful also to follow up and treat aged patients.”

iMedX is being adopted for public use right at its home, IIT Kharagpur on-campus healthcare system.

Director, Prof. V K Tewari stated, “In April we had announced eight R&D projects for providing COVID healthcare services. This telemedicine project is the key among them, especially, keeping in mind its effectiveness in our own community. When our campus will start operating in full strength close to 30000 people including students would be in need of healthcare services and this technology will reduce over-exposure of the healthcare staff while efficiently catering to the population. While we are promoting physical distancing, it seems only appropriate to introduce this digital platform to meet the healthcare needs of the campus community effectively. We are creating user accounts for our medical cardholders who can avail the consultation facility home through video conferencing”.

The software was launched on October 2, 2020, on the occasion of Gandhi Jayanti and will be integrated at the Dr B. C. Roy Technology Hospital of the Institute which provides emergency healthcare services for the campus residents and employees, confirmed the office of Principal Medical Officer Dr Samir Dasgupta.


Deputy Director, Prof. S K Bhattacharyya remarked, “Since we have a large number of OPD patients, it will be extremely beneficial to them as the movement to the hospital is extremely difficult for them. Also, for our students, the waiting time at the hospital will get reduced as this will be very helpful to them.”

A base model was installed at Swasthya Bhawan, Govt. of West Bengal on trial basis. Field trials are also underway for the base model at Bangladesh.

Director Tewari further shared his plan to expand the use of this technology to the people outside the campus through the upcoming super-speciality hospital of IIT Kharagpur.

The researchers are already in touch with healthcare MSMEs for commercialization of the copyrighted version of the technology.

Continue Reading

COVID19

COVID-19: 6Cr Indians Likely Exposed To Corona – 2nd ICMR Sero-Survey

Urban slum & non-slum areas have a higher prevalence of Corona infection than rural areas.

Published

on

NEW DELHI: ICMR’s second sero-survey findings released on Tuesday has revealed that one in 15 individuals aged 10 years and above were estimated to be exposed to SARS-CoV2 by August, showing that a considerable population is still susceptible to COVID-19.

Briefing media on Tuesday, DG ICMR Dr Balram Bhargava said, 6.6 per cent of over 29 thousand people, aged 10 and above, surveyed from 17th August to 22nd September showed evidence of past exposure to COVID-19 and 7.1 per cent of the adult population, aged 18 and above, also showed evidence of past exposure to it.

He said lockdown, containment and behavioural change at the population level have effectively checked the potential spread of SARS-CoV2.


Dr Bhargava said the risk in urban slums was twice than that in non-slum urban areas and four times the risk in rural settings.

He said that the second sero-survey was conducted in the same 700 villages and wards from 70 districts from 21 states which were covered during the first survey.

But this time, it surveyed different households and individuals.


The ICMR DG said, since a large proportion of the population is still susceptible, prevention fatigue has to be avoided and the 5T strategy — test, track, trace, treat, technology — has to be adhered to.

Continue Reading

Most Read This Month

error: Content on this news portal is protected!